Vanderbilt University Medical Center, Nashville, Tennessee.
Vanderbilt University School of Medicine, Nashville, Tennessee.
Arthritis Rheumatol. 2020 Sep;72(9):1483-1492. doi: 10.1002/art.41291. Epub 2020 Aug 6.
This study was undertaken to investigate the hypothesis that a genetic predisposition toward rheumatoid arthritis (RA) increases the risk of 10 cardiometabolic and autoimmune disorders previously associated with RA in epidemiologic studies, and to define new genetic pleiotropy present in RA.
Two approaches were used to test our hypothesis. First, we constructed a weighted genetic risk score (wGRS) and then examined its association with 10 prespecified disorders. Additionally, a phenome-wide association study (PheWAS) was carried out to identify potential new associations. Second, inverse variance-weighted regression (IVWR) meta-analysis was used to characterize the association between genetic susceptibility to RA and the prespecified disorders, with the results expressed as odds ratios (ORs) and 95% confidence intervals (95% CIs).
The wGRS for RA was significantly associated with type 1 diabetes mellitus (DM) (OR 1.10 [95% CI 1.04-1.16]; P = 9.82 × 10 ) and multiple sclerosis (OR 0.82 [95% CI 0.77-0.88]; P = 1.73 × 10 ), but not with other cardiometabolic phenotypes. In the PheWAS, wGRS was also associated with an increased risk of several autoimmune phenotypes including RA, thyroiditis, and systemic sclerosis, and with a decreased risk of demyelinating disorders. In the IVWR meta-analyses, RA was significantly associated with an increased risk of type 1 DM (P = 1.15 × 10 ), with evidence of horizontal pleiotropy (Mendelian Randomization-Egger intercept estimate P = 0.001) likely driven by rs2476601, a PTPN22 variant. The association between type 1 DM and RA remained significant (P = 9.53 × 10 ) after excluding rs2476601, with no evidence of horizontal pleiotropy (intercept estimate P = 0.939). RA was also significantly associated with type 2 DM and C-reactive protein levels. These associations were driven by variation in the major histocompatibility complex region.
This study presents evidence of pleiotropy between the genetic predisposition to RA and associated phenotypes found in other autoimmune and cardiometabolic disorders, including type 1 DM.
本研究旨在验证下述假说,即类风湿关节炎(RA)的遗传易感性会增加流行病学研究中与 RA 相关的 10 种心血管代谢和自身免疫性疾病的风险,并确定 RA 中存在的新的遗传多效性。
采用两种方法检验我们的假说。首先,构建加权遗传风险评分(wGRS),然后检验其与 10 种预先指定疾病的相关性。此外,还进行了表型全基因组关联研究(PheWAS)以鉴定潜在的新关联。其次,采用逆方差加权回归(IVWR)荟萃分析来描述 RA 的遗传易感性与预先指定疾病之间的关联,结果以比值比(OR)和 95%置信区间(95%CI)表示。
RA 的 wGRS 与 1 型糖尿病(DM)(OR 1.10 [95%CI 1.04-1.16];P=9.82×10)和多发性硬化症(OR 0.82 [95%CI 0.77-0.88];P=1.73×10)显著相关,但与其他心血管代谢表型无关。在 PheWAS 中,wGRS 也与包括 RA、甲状腺炎和系统性硬化症在内的几种自身免疫表型的风险增加相关,与脱髓鞘疾病的风险降低相关。在 IVWR 荟萃分析中,RA 与 1 型 DM 的风险增加显著相关(P=1.15×10),存在水平多效性的证据(孟德尔随机化-Egger 截距估计 P=0.001),这可能由 PTPN22 变体 rs2476601 驱动。在排除 rs2476601 后,1 型 DM 和 RA 之间的关联仍然显著(P=9.53×10),且不存在水平多效性(截距估计 P=0.939)。RA 还与 2 型 DM 和 C 反应蛋白水平显著相关。这些关联是由主要组织相容性复合物区域的变异驱动的。
本研究提供了 RA 的遗传易感性与其他自身免疫性和心血管代谢疾病相关表型之间存在多效性的证据,包括 1 型 DM。